Key result
Anti-HEV IgG seroprevalence was similar between 138 HIV-infected patients and 464 controls, with no evidence of chronic HEV coinfection found in the HIV cohort.
Why the study?
What is the incidence of chronic HEV coinfection and anti-HEV seroprevalence in patients with HIV infection compared to controls?
Case-Control (n=602)
Yes
What is the incidence of chronic HEV coinfection and anti-HEV seroprevalence in patients with HIV infection compared to controls?
Chronic HEV coinfection is not a common problem in patients with HIV infection in southwest England, and seroprevalence is similar to the general population.
Answers are grounded in this paper and cite their sources.
Chronic HEV coinfection appears uncommon in this HIV cohort; hypothesis-generating and should not yet alter screening practices.
No takes yet. Share an insight, caveat, or question.
Keane et al. (2011) conducted a case-control in HIV infection (n=602). HIV infection vs. Control subjects was evaluated on Anti-HEV IgG seroprevalence. Anti-HEV IgG seroprevalence was similar between 138 HIV-infected patients and 464 controls, with no evidence of chronic HEV coinfection found in the HIV cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: